(Q43518370)

24 November 2017

Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides (English)

1 reference

24 November 2017

2

Elena Britan-Rosich

1 reference

24 November 2017

9

Robert Blumenthal

1 reference

24 November 2017

Tali H Reingewertz

1

1 reference

24 November 2017

Shahar Rotem-Bamberger

3

1 reference

24 November 2017

Mathias Viard

4

1 reference

24 November 2017

Amy Jacobs

5

1 reference

24 November 2017

Abigail Miller

6

1 reference

24 November 2017

Ji Youn Lee

7

1 reference

24 November 2017

Jeeseong Hwang

8

1 reference

24 November 2017

Moshe Kotler

10

1 reference

24 November 2017

Assaf Friedler

11

1 reference

24 November 2017

language of work or name

English

0 references

publication date

14 March 2013

1 reference

Bioorganic & Medicinal Chemistry

24 November 2017

1 reference

24 November 2017

21

1 reference

24 November 2017

12

1 reference

24 November 2017

3523-3532

1 reference

A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.

24 November 2017

1 reference

12 December 2020

Advances in the structural understanding of Vif proteins

1 reference

12 December 2020

Retroviral restriction by APOBEC proteins

1 reference

12 December 2020

Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G

1 reference

12 December 2020

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process

1 reference

12 December 2020

The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex

1 reference

12 December 2020

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

12 December 2020

Mice deficient in APOBEC2 and APOBEC3.

1 reference

12 December 2020

A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor

1 reference

12 December 2020

Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation

1 reference

12 December 2020

Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif.

1 reference

12 December 2020

An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model

1 reference

12 December 2020

Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors

1 reference

12 December 2020

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

12 December 2020

Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G

1 reference

12 December 2020

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

12 December 2020

Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity

1 reference

12 December 2020

Clustal W and Clustal X version 2.0

1 reference

12 December 2020

HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation

1 reference

12 December 2020

DNA deamination mediates innate immunity to retroviral infection

1 reference

12 December 2020

Small-molecule inhibition of HIV-1 Vif.

1 reference

12 December 2020

Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity

1 reference

12 December 2020

Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase

1 reference

12 December 2020

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

1 reference

12 December 2020

The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1

1 reference

12 December 2020

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

1 reference

12 December 2020

Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription

1 reference

12 December 2020

Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulations

1 reference

12 December 2020

Model structure of human APOBEC3G

1 reference

12 December 2020

HIV-1 Vif: HIV's weapon against the cellular defense factor APOBEC3G.

1 reference

12 December 2020

Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor

1 reference

12 December 2020

The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G

1 reference

12 December 2020

RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1

1 reference

12 December 2020

Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly

1 reference

12 December 2020

The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells

1 reference

12 December 2020

Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production

1 reference

12 December 2020

Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization

1 reference

12 December 2020

A solubility-enhancement tag (SET) for NMR studies of poorly behaving proteins.

1 reference

12 December 2020

Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction

1 reference

12 December 2020

Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

1 reference

12 December 2020

A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action

1 reference

12 December 2020

Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding

1 reference

12 December 2020

Studying protein-protein interactions using peptide arrays.

1 reference

12 December 2020

Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region

1 reference

12 December 2020

Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.

1 reference

12 December 2020

Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors

1 reference

12 December 2020

Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.

1 reference

12 December 2020

The role of Vif during HIV-1 infection: interaction with novel host cellular factors

1 reference

12 December 2020

Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation

1 reference

12 December 2020

Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene

1 reference

12 December 2020

Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression

1 reference

12 December 2020

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

1 reference

12 December 2020

Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

1 reference

12 December 2020

A zinc-binding region in Vif binds Cul5 and determines cullin selection

1 reference

12 December 2020

A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

1 reference

12 December 2020

Structural disorder in the HIV-1 Vif protein and interaction-dependent gain of structure

1 reference

12 December 2020

High-throughput human immunodeficiency virus type 1 (HIV-1) full replication assay that includes HIV-1 Vif as an antiviral target

1 reference

12 December 2020

Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.

1 reference

12 December 2020

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

12 December 2020

HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain

1 reference

12 December 2020

Complementary function of the two catalytic domains of APOBEC3G.

1 reference

12 December 2020

Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.

1 reference

12 December 2020

The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation

1 reference

12 December 2020

HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.

1 reference

12 December 2020

MDM2 is a novel E3 ligase for HIV-1 Vif.

1 reference

12 December 2020

HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors

1 reference

12 December 2020

The current structural and functional understanding of APOBEC deaminases

1 reference

12 December 2020

Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA

1 reference

12 December 2020

The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state.

1 reference

12 December 2020

Characterization of a novel Cullin5 binding domain in HIV-1 Vif.

1 reference

12 December 2020

HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes

1 reference

12 December 2020

Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.

1 reference

12 December 2020

Replication potentials of vif variant viruses generated from monkey cell-tropic HIV-1 derivative clones NL-DT5/NL-DT5R.

1 reference

12 December 2020

Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity

1 reference

12 December 2020

The APOBEC3C crystal structure and the interface for HIV-1 Vif binding

1 reference

12 December 2020

Phosphorylation of Vif and its role in HIV-1 replication

1 reference

12 December 2020

Calculation of protein extinction coefficients from amino acid sequence data

1 reference

12 December 2020

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

12 December 2020

The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity

1 reference

12 December 2020

HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation

1 reference

12 December 2020

10.1016/J.BMC.2013.03.001

Identifiers

DOI

1 reference

release_tyohl7a43vgozdo5aeth4bzfh4

24 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tyohl7a43vgozdo5aeth4bzfh4

24 November 2022

mapped directly with Wikidata item

0 references

1 reference